试验 发表于 2025-3-23 12:13:10

Submitted on: 17 October 2023.
Revised on: 21 November 2023.
Accepted on: 06 December 2023.

___________________Indian Journal of Vascular and Endovascular Surgery

HPA533 发表于 2025-3-23 17:44:04

Submitted on: 24 April 2017.
Revised on: 13 August 2017.
Accepted on: 20 September 2017.

___________________Indian Journal of Vascular and Endovascular Surgery

Opponent 发表于 2025-3-23 19:44:16

http://reply.papertrans.cn/2/125/12423/12423-13.png

潜伏期 发表于 2025-3-24 01:48:07

http://reply.papertrans.cn/2/125/12423/12423-14.png

mediocrity 发表于 2025-3-24 05:40:46

Submitted on: 11 July 2021.
Revised on: 15 October 2021.
Accepted on: 04 December 2021.

___________________Indian Journal of Vascular and Endovascular Surgery

Blazon 发表于 2025-3-24 09:37:34

http://reply.papertrans.cn/2/125/12423/12423-16.png

圆木可阻碍 发表于 2025-3-24 10:51:40

Submitted on: 20 July 2023.
Revised on: 21 August 2023.
Accepted on: 08 September 2023.

___________________Indian Journal of Vascular and Endovascular Surgery

Subjugate 发表于 2025-3-24 16:30:04

Submitted on: 20 December 2013.
Revised on: 03 April 2014.
Accepted on: 22 April 2014.

___________________Indian Journal of Vascular and Endovascular Surgery

chassis 发表于 2025-3-24 22:11:03

http://reply.papertrans.cn/2/125/12423/12423-19.png

小丑 发表于 2025-3-24 23:32:57

Submitted on: 18 April 2021.
Revised on: 13 June 2021.
Accepted on: 30 June 2021.

___________________Indian Journal of Vascular and Endovascular Surgery
页: 1 [2] 3 4
查看完整版本: ESCI期刊Indian Journal of Vascular and Endovascular Surgery 2024/2025影响因子:0.123 (INDIAN J VASCULAR EN) (0972-0820). (CARD